We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.99%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
-$3.99B
(-7.1%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-2.32%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
1,740
New
31
Increased
388
Reduced
563
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$151M |
| 2 |
Johnson & Johnson
JNJ
|
+$111M |
| 3 |
Atlassian
TEAM
|
+$95.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$77.2M |
| 5 |
Capital One
COF
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$302M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$156M |
| 3 |
Apple
AAPL
|
+$132M |
| 4 |
Meta Platforms (Facebook)
META
|
+$95.1M |
| 5 |
NVIDIA
NVDA
|
+$94.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.6% |
| 2 | Financials | 14.62% |
| 3 | Healthcare | 13.57% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
W.P. Carey
WPC
$16.6B
| $6.3M | 0.01% |
99,841
-56,250
| -36% | -$3.33M |
|
|
CNTA
577
DELISTED
Centessa Pharmaceuticals
CNTA
| $6.3M | 0.01% |
438,133
+359,133
| +455% | +$5.88M |
|
578
Cooper Companies
COO
$14.2B
| $6.3M | 0.01% |
74,644
-581
| -0.8% | -$52.1K |
|
|
AKRO
579
DELISTED
Akero Therapeutics
AKRO
| $6.28M | 0.01% |
155,044
| – | – |
|
580
Jabil
JBL
$30.1B
| $6.26M | 0.01% |
46,012
-2,000
| -4% | -$308K |
|
581
Hubbell
HUBB
$24.4B
| $6.26M | 0.01% |
18,918
-770
| -4% | -$298K |
|
582
Avery Dennison
AVY
$12.8B
| $6.25M | 0.01% |
35,121
-2,520
| -7% | -$463K |
|
583
Lamar Advertising Co
LAMR
$16.7B
| $6.23M | 0.01% |
54,787
+2,713
| +5% | +$330K |
|
|
TTAN
584
ServiceTitan Inc
TTAN
$8.03B
| $6.18M | 0.01% |
+65,000
| New | +$6.3M |
|
585
Equity Residential
EQR
$25.8B
| $6.18M | 0.01% |
86,270
-8,287
| -9% | -$585K |
|
586
KeyCorp
KEY
$23.8B
| $6.17M | 0.01% |
385,845
-2,603
| -0.7% | -$44.2K |
|
587
Enbridge
ENB
$120B
| $6.12M | 0.01% |
138,350
-4,300
| -3% | -$187K |
|
588
Gen Digital
GEN
$16.5B
| $6.11M | 0.01% |
230,350
+1,241
| +0.5% | +$34K |
|
589
Mirum Pharmaceuticals
MIRM
$6.56B
| $6.04M | 0.01% |
133,973
-84,615
| -39% | -$3.99M |
|
590
CF Industries
CF
$19.6B
| $5.99M | 0.01% |
76,623
-31,839
| -29% | -$2.67M |
|
591
UDR
UDR
$12.9B
| $5.97M | 0.01% |
132,234
+25,530
| +24% | +$1.09M |
|
592
Lantheus
LNTH
$6.51B
| $5.95M | 0.01% |
60,913
+19,518
| +47% | +$1.83M |
|
593
Kimco Realty
KIM
$17.5B
| $5.88M | 0.01% |
276,960
-28,995
| -9% | -$633K |
|
594
ON Semiconductor
ON
$30.7B
| $5.88M | 0.01% |
144,400
-350
| -0.2% | -$17.6K |
|
595
Assurant
AIZ
$13.9B
| $5.87M | 0.01% |
27,975
-3,571
| -11% | -$745K |
|
596
Evercore
EVR
$11.8B
| $5.81M | 0.01% |
29,094
+4,680
| +19% | +$1.17M |
|
|
SLNO
597
DELISTED
Soleno Therapeutics
SLNO
| $5.79M | 0.01% |
81,063
+71,862
| +781% | +$3.5M |
|
598
Halliburton
HAL
$26.1B
| $5.79M | 0.01% |
228,155
-1,702
| -0.7% | -$44.8K |
|
599
SLB Ltd
SLB
$72.7B
| $5.78M | 0.01% |
138,350
-112,989
| -45% | -$4.63M |
|
600
Dick's Sporting Goods
DKS
$18.4B
| $5.78M | 0.01% |
28,662
-9,753
| -25% | -$2.18M |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Ensign Peak Advisors held 1,740 positions worth $52.3B, down 7.1% from $56.3B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4.7%. Ensign Peak Advisors opened 31 new positions and exited 51, leaving the 1,740-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q1 2025 buy was iShares Russell 2000 ETF: 355,907 shares worth $71M.
- Ensign Peak Advisors added most to FTAI Aviation in Q1 2025, an estimated $151M increase.
- Ensign Peak Advisors's biggest Q1 2025 reduction was Thermo Fisher Scientific, cutting an estimated $156M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2025, selling an estimated $302M.
- Ensign Peak Advisors's ten largest holdings make up 30% of its $52.3B portfolio in Q1 2025.
- Ensign Peak Advisors opened 31 new positions and closed 51 in Q1 2025.
- Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q1 2025, filed 14 May 2025.